ME Therapeutics: Funding, Investors & Team (Sep 2026)
ME Therapeutics is a biotech company that specializes in finding and creating drugs for immuno-oncology that target Myeloid cells.
ME Therapeutics has raised $460k across 2 funding rounds on record, the most recent an undisclosed round of $360k announced in Jun 2026.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
ME Therapeutics Company Profile and Key Stats
Latest funding round on record: Jun 2026.
ME Therapeutics Funding Rounds
ME Therapeutics raised $100k in an undisclosed round announced in May 2025.
1.1 years later, an undisclosed round of $360k was announced in Jun 2026.
ME Therapeutics Founders and Leadership Team
Contact details for the ME Therapeutics team: 1 of 1 has an email address on file.
Start 14-day free trial →ME Therapeutics Funding Compared to Other Biotechnology Startups
ME Therapeutics' latest round of $360k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like ME Therapeutics in Biotechnology and Vancouver
Companies Similar to ME Therapeutics
Medicenna is a clinical-stage immunotherapy company focused on oncology and the development and…
Cybin is a clinical-stage biopharmaceutical company on a mission to create safe and effective…
Hemostemix Inc. is a Canadian biotechnology company that specializes in creating blood-derived cell therapies…
Avicanna is an organization in the biopharmaceutical sector that concentrates on enhancing medical cannabis…
Edesa Biotech is a privately-held company in the clinical stage that specializes in creating therapies for…
Aurinia Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing and…
Medicus Pharma is a biotechnology research company that fast-tracks the progress of life sciences and…
ProteinQure is a biotechnology company specializing in creating innovative peptides for various medical…
Anodyne's mission is to create critical chemicals sustainably. Anodyne's approach takes advantage of nature's…
NervGen Pharma is a medicine company dedicated to creating solutions for the treatment of nerve damage and…
ZYUS is a biopharmaceutical company focused on providing patients with cannabinoids and other plant-based…
Resverlogix Corporation, a biopharmaceutical company, focuses on the development of novel therapeutics in…
ME Therapeutics Funding FAQs
What does ME Therapeutics do?
ME Therapeutics is a biotech company that specializes in finding and creating drugs for immuno-oncology that target Myeloid cells.
How much funding has ME Therapeutics raised?
ME Therapeutics has raised $460k across 2 rounds on record. The most recent is an undisclosed round of $360k announced in Jun 2026.
When did ME Therapeutics last raise funding?
ME Therapeutics' most recent funding round on record is an undisclosed round of $360k, announced in Jun 2026.
Who founded ME Therapeutics?
FundedIQ lists Salim Dhanji (Founder) at ME Therapeutics.
Where is ME Therapeutics headquartered?
ME Therapeutics is based in Vancouver, British Columbia, Canada.
How many employees does ME Therapeutics have?
ME Therapeutics is in the 11-50 employee band.
How does ME Therapeutics' funding compare to other Biotechnology startups?
ME Therapeutics' latest round of $360k is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's ME Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for ME Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.